Finally, a pharmacy service that delivers on the promise.™

       
Visit us on Twitter
Company
Customer Site Visit
Request A Discovery Meeting

Board of Directors

Richard Scardina (Chairman)

Mr. Scardina has been a director of Millennium since October 2007 and served as Chief Executive Officer September 2008 until he assumed the role of Chairman of the Board effective July 2012. He is a proven health care services executive with experience in rapid growth and innovation in businesses including long-term care pharmacy, pharmacy benefit management, disease management, infusion therapy and specialty pharmacy. Prior to his time with Millennium, Mr. Scardina was a private investor and business consultant primarily to health care related organizations. From July 1989 until May 2006 he was employed by Caremark Rx and its predecessor companies, most recently as executive vice president of operations, and Baxter International. Before that, Mr. Scardina was an employee of Price Waterhouse for thirteen years. He was also previously chairman and an executive committee member of the Pharmacy Care Management Association, the trade association for the pharmacy benefit management industry.

Mr. Scardina earned a bachelor's of science degree in accounting with high honors from the University of Illinois and is a certified public accountant.

Damian N. Dell'Anno

Prior to co-founding Next Step Healthcare, Mr. Dell’Anno served as CEO and President at Genoa Healthcare, Senior Executive Vice President and COO of Formation Capital as well as CEO, President and Chairman of Harborside Healthcare. He joined Harborside Healthcare in 1989, was promoted to Chief Operating Officer in 1994, President in 2000, and was then named Chief Executive Officer and Chairman in 2005. Before joining Harborside, Mr. Dell'Anno served as Director of Budget, Reimbursement, for the Mediplex Group, Inc., from 1988 to 1989. Prior to that he held several other positions in the health care services sector. Mr. Dell’Anno is a past member of the Board of Directors, Alliance for Quality Nursing Home Care, Inc. and the Massachusetts, Connecticut and Ohio State Nursing Home Associations. Mr. Dell'Anno has a B.S.B.A. degree in accounting from Suffolk University.

Tamara Elias, M.D.

Tamara Elias, M.D., is a physician and Partner at Essex Woodlands, a globally based health care-focused growth equity firm with $2.5 billion in assets under management. She brings over 15 years of healthcare experience to the Firm, which she joined in 2007. Prior to Essex, Dr. Elias spent six years at McKinsey & Company, a global management consulting firm where she advised pharmaceutical and diagnostic companies in strategic, operational, and business development areas, managing numerous teams. Prior to joining McKinsey, Dr. Elias was a general surgery resident at Massachusetts General Hospital in Boston after receiving her M.D. at Johns Hopkins School of Medicine.

Dr. Elias is a Kauffman Fellow and an organizing member of MedtechWomen for women leaders in the industry, which hosts an annual MedtechVision conference to discuss the most challenging issues facing the sector and propose solutions.

Myles D. Greenberg, M.D.

Dr. Greenberg joined CHL Medical Partners in 2004. Previously, he was a Senior Principal at A. M. Pappas & Associates and held a faculty appointment as an Assistant Professor at the University of North Carolina School of Medicine. Prior to becoming a venture capitalist, Dr. Greenberg was Assistant Clinical Director and Instructor of Emergency Medicine in the Department of Emergency Medicine at Beth Israel Deaconess Medical Center, Harvard Medical School. His professional affiliations include being a Diplomat with the American Board of Emergency Medicine and a Fellow of the American College of Emergency Physicians. Dr. Greenberg currently serves on the board of two portfolio companies, Millennium Pharmacy Systems, Inc. and Oculir, Inc., and has previously served on the boards of Angiomics, Dynogen, FlowCardia, and NuVasive. He was also an observer member of the boards of ArgoMed, LipoScience, and Syntonix. Dr. Greenberg received his B.A.S. from the University of Pennsylvania School of Engineering and Applied Science. He holds an M.D. from the Yale University School of Medicine and an MBA from the Harvard Business School.

Jonathan Perl

Mr. Perl has more than 8 years of investing experience, focused primarily on early-stage information technology and life science companies. He led the BVIV investments in iLumin Software, Rannoch and Millennium Pharmacy Systems. ILumin was sold to Computer Associates (NYSE: CA) in October 2005. He was a Partner in BVIV and will be a General Partner in BV V. Mr. Perl joined Intersouth Partners in 1997 as a member of the third class of Kauffman Fellows. In 1999, he became a Partner. He was responsible for the sourcing, due diligence, structuring and negotiation of more than a dozen early stage investments, including several highly successful companies. From 1991 to 1995, Mr. Perl was the Director of Washington Operations for IICC, a placement agent, where he was responsible for a variety of consulting arrangements with both investment management firms and venture backed companies. Prior to joining IICC, Mr. Perl was in the management development program at American Security Bank (now BofA). Mr. Perl holds an MBA from the Amos Tuck School of Business at Dartmouth College (1997) and a BA (magna cum laude) in classical history from Tufts University (1988).

Steve Wiggins

Steve Wiggins founded Oxford Health Plans and served 14 years as the company's Chairman of the Board and Chief Executive Officer. Under his leadership, Oxford grew to over $5 billion in annual revenue and ranked among the 300 largest U.S. corporations. He was also the Founder, Chairman and Chief Executive Officer of HealthMarket, Inc., an insurance company that gave birth to innovative Consumer Driven Health Plans and grew to over $150 million in revenue before being acquired by UICI. He co-founded Health Partners, Inc, a physician practice management company that grew to $140 million in annual revenue before it was sold. He was also a co-Founder of Intelliclaim, Inc., which provided claim auditing and productivity software and services to over twenty health insurers before it was sold to McKesson and he was the founding investor in BenefitPort, LLC, a consolidation of health insurance general agencies.

He has also been an active private equity investor on his own and in partnership with private equity funds, typically originating transactions or organizing new businesses. He is a co-founder of Centerstone Partners, which has conceived, launched and continues to provide management services to Amerigen Pharmaceuticals, Inc, Revogenix, Inc. and CTC Electric, LLC. He is also a co-founder and Senior Advisor of ArrowHawk Capital, a multi-strategy hedge fund.

Mr. Wiggins joined Essex Woodlands in 2007. He serves on the Board of Directors for Touchstone Health Partnership, Inc. and Ika Systems. He is a Director of Accessible Space, Inc, a nonprofit organization he founded in 1978, that develops and operates residential facilities for individuals with mobility impairments and brain injuries. Mr. Wiggins holds an M.B.A. from Harvard Business School and a B.A. from Macalester College, where he currently serves as a Trustee.